Bleichroeder LP’s Eterna Therapeutics ERNA Stock Holding History

Bleichroeder LP’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-80,000	Closed	-$398K	–	81
2026 Q1	$398K	Buy	+80,000	New	+$1.28M	0.07%	52

Other funds holding ERNA

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tradewinds Capital Management Bellingham, Washington $563M AUM 41.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Bleichroeder LP's ERNA Position: Q2 2026 in Review

Bleichroeder LP sold out of Eterna Therapeutics (ERNA) in Q2 2026, closing a stake of 80,000 shares — an estimated $398K sold.

Bleichroeder LP first reported a position in ERNA in Q1 2026 and held it in 1 quarter. The position peaked at $398K in Q1 2026. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2026.

Bleichroeder LP reported no remaining Eterna Therapeutics position as of Q2 2026 after selling out during the quarter.
Bleichroeder LP sold 80,000 Eterna Therapeutics shares in Q2 2026, an estimated $398K.
Bleichroeder LP first reported a position in Eterna Therapeutics in Q1 2026 and held it in 1 quarter.
Bleichroeder LP's Eterna Therapeutics position peaked at $398K in Q1 2026.
9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.